“…Anaplastic meningioma, classified as a WHO grade III, is a rare subtype, accounting for 1%-3% of all meningiomas [ 1 ]. They are highly aggressive with a worse clinical course, including a higher risk of recurrence ranging from 50% to 94%, and increased mortality, with the median survival typically less than 2 years and the 5-year survival ranging from 35% to 61% [ [2] , [3] , [4] ]. Pediatric meningioma, while rare, also presents a worse prognosis compared to adults [ 5 ].…”